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Abstract. It is widely accepted that cervical screening has significantly reduced the incidence of cervical cancer
worldwide. The primary screening test for cervical cancer is the Papanicolaou (Pap) test, which has extremely
variable specificity and sensitivity. There is an unmet clinical need for methods to aid clinicians in the early
detection of cervical precancer. Raman spectroscopy is a label-free objective method that can provide a biochemical fingerprint of a given sample. Compared with studies on infrared spectroscopy, relatively few Raman
spectroscopy studies have been carried out to date on cervical cytology. The aim of this study was to define the
Raman spectral signatures of cervical exfoliated cells present in liquid-based cytology Pap test specimens and to
compare the signature of high-grade dysplastic cells to each of the normal cell types. Raman spectra were
recorded from single exfoliated cells and subjected to multivariate statistical analysis. The study demonstrated
that Raman spectroscopy can identify biochemical signatures associated with the most common cell types seen
in liquid-based cytology samples; superficial, intermediate, and parabasal cells. In addition, biochemical
changes associated with high-grade dysplasia could be identified suggesting that Raman spectroscopy
could be used to aid current cervical screening tests. © 2017 Society of Photo-Optical Instrumentation Engineers (SPIE) [DOI:
10.1117/1.JBO.22.10.105008]

Keywords: Raman spectroscopy; cytology; ThinPrep; exfoliated cells; superficial cells; intermediate cells; parabasal cells; cervical
cancer; cervical dysplasia.
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1

Introduction

Cervical cancer is the fourth most common malignancy among
women worldwide, with an estimated 528,000 cases diagnosed
in 2012. Of these, 266,000 women died, with 87% of the deaths
occurring in lower-income countries.1 Cervical intraepithelial
neoplasia (CIN) is the premalignant stage of cervical cancer
and can be classified as low grade (CIN1) and high grade
(CIN2/3).2
The gradual progression of cervical cancer allows for the
application of screening programs to detect preneoplastic
changes before invasive cancer develops. The Papanicolaou
(Pap) test is the primary approach to cervical cancer screening.
This is a screening test that allows detection of cytological
abnormalities of the endocervix and ectocervix. A cervical
smear is taken, which is then cytologically examined with
the help of a Pap stain.3 However, the Pap test displays a hugely
variable sensitivity and specificity. Arbyn et al.4 reported a sensitivity of 90.4% and a specificity of 64.6% of Pap cytology for
detection of CIN2+, although these results are known to vary
between hospitals.
Human papillomavirus (HPV) is the main causative agent of
cervical cancer and so HPV DNA testing has recently been
incorporated into cervical screening programs.5 However,
while the sensitivity of HPV testing exceeds that of cytology,

HPV testing has not been able to match the specificity of
cytology.6
The development of an alternative to the current approaches
is long overdue. Raman spectroscopy is a vibrational spectroscopic technique that has the potential to combine the diagnostic
advantages of both cytology and HPV testing. Raman spectroscopy can provide a rapid, label-free, nondestructive measurement of the complete biochemical fingerprint of cells or
tissues. If Raman spectroscopy can be shown to be as good as,
or better than, the current gold standard, then there is great
potential for the technique to be used as an alternative or an
adjunct to the Pap smear test, which is available through screening programs in most developed countries. In developing countries, however, because of a lack of resources and infrastructure,
screening programs are not available and a “see and treat”
approach based on visual inspection using acetic acid may be
more appropriate in this setting.7 With clinical translation to
lower cost, automated Raman systems, the advantages would
be higher sample throughput and less requirement for highly
trained cytologists and pathologists to implement the screening
program.
Over the past 15 years, the potential of Raman spectroscopy
together with multivariate statistical analysis has been demonstrated for the detection of a variety of cancers, including cervical cancer.8–10 The majority of Raman spectroscopy studies
on cervical cancer has focused on cervical tissue ex vivo11–15
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or in vivo,16–20 with relatively few studies focusing on cervical
cytology.21–24 Extensive studies have, however, been carried out
on exfoliated cervical cells using infrared spectroscopy. Early
studies by Wong et al.25 showed significant differences between
normal, precancer, and cancer samples but as spectra were
recorded from cell pellets rather than from single exfoliated
cells, a number of confounding factors, such as polymorphs,
endocervical columnar cells, metaplastic cells, cervical mucus,
and debris, were subsequently identified.26–29 More recent infrared studies using liquid-based cytology have shown significant
spectral differences between normal, low-grade, and high-grade
dysplasia.30–32 Recent Raman spectroscopy studies showed that
HPV-positive and HPV-negative cytology samples could be
classified with an accuracy of 98.5%21 and that normal and cervical cancer cytology samples could be classified with an accuracy of ∼80%.22 Both of these studies used cell pellets rather
than recording Raman spectra from single exfoliated cells
and this probably resulted in the relatively low classification
accuracy in the study by Rubina et al.22 due to sample heterogeneity. Recent studies from our group have shown that Raman
spectra can be successfully recorded from single exfoliated cells
from liquid-based cytology Pap test specimens.23,24 Many of the
issues involved in recording Raman spectra from cervical cytology specimens prepared according to the standard clinical protocols as single exfoliated cells on ThinPrep glass slides were
addressed by Bonnier et al.23 and a pretreatment of the slides
with hydrogen peroxide to clear blood residue contamination
before Raman recording was shown to minimize variability
within the data sets resulting in highly reproducible data.
Ramos et al.24 reported sensitivity and specificity values of
>90% for classification of negative, CIN1, CIN2, and CIN3 cervical cytology samples. Recently, Traynor et al.33 investigated
hormone-associated changes in the Raman spectra of cytologically negative ThinPrep cervical smear samples related to the
menstrual cycle, the use of hormone-based contraceptives,
and the onset of menopause, and showed that any spectral
changes did not interfere with the ability to discriminate
between normal and abnormal cervical cytology samples.
This study follows on from this and focuses on defining the
spectral signatures of different types of cervical exfoliated
cells. Most Pap test specimens contain a variety of different
cell types. These include superficial cells, intermediate cells,
parabasal cells, white blood cells, endocervical cells, and squamous metaplastic cells. The most abundant of these cell types
are superficial and intermediate cells, while parabasal cells are
also commonly seen depending on certain factors. The ratio of
superficial to intermediate cells is governed by the hormonal
status of the patient, i.e., last menstrual period, use of oral contraceptive pill, or intrauterine contraceptive device.34 As the cervix matures, the number of superficial cells tends to increase,
while women taking the oral contraceptive pill tend to produce
samples that contain a higher quantity of intermediate cells.
In addition, the lack of estrogenic stimulation after menopause
results in the loss of cervical cell differentiation, so more
parabasal cells are seen in the smear. An increase in parabasal
cells is also observed when the patient is exhibiting cervical
atrophy.
While the infrared and Raman spectral signatures of superficial, intermediate, and parabasal cell layers have previously
been investigated in cervical tissue,14,15,35,36 to the best of our
knowledge, this has not previously been investigated in single
exfoliated cervical cells.
Journal of Biomedical Optics

In this study, Raman spectral signatures of cervical epithelial
cells—superficial, intermediate, and parabasal cells—are presented and it is shown that they can be discriminated from
each other. In addition, the spectral signature of high-grade
dysplastic cervical cells was compared to each of the normal
cervical epithelial cell types.

2
2.1

Materials and Methods
Sample Collection and Preparation

Liquid-based cervical cytology samples collected in PreservCyt
were obtained from the Cytopathology Department of the
Coombe Women and Infants University Hospital. The study
population was an anonymized group of women that had
given a smear for routine screening. The cervical cells are collected by a clinician using a cervix brush or a combination of
a spatula and cytobrush, before transfer of the cells into a
ThinPrep vial containing a methanol-based fixative solution
called PreservCyt. A total of 70 liquid-based cytology cervical
samples, 20 confirmed as cytology negative, and 50 confirmed
as high-grade dyskaryosis was used for this study. Ethical approval was obtained from the Research Ethics Committee of the
Coombe Women and Infants University Hospital. Once routine
cytological diagnosis based on the Pap test was performed, the
residual material was used for this study. Cytological diagnoses
are reported according to the Bethesda system, such that samples containing low- and high-grade abnormalities are classed,
respectively, as low-grade squamous intraepithelial lesion
(LSIL) and high-grade squamous intraepithelial lesion (HSIL).
LSIL is usually indicative of CIN1, whereas HSIL is indicative
of CIN2 or CIN3.37
A further set of liquid-based cytology cervical samples,
confirmed as cytology negative, was obtained from patients
who had an endometrial biopsy taken on the same day as
the smear test (n ¼ 10). The phase in the menstrual cycle, for
each sample, could be confirmed by the corresponding endometrial biopsy. Samples from the proliferative phase (days 5
to 13) (n ¼ 4), the secretory phase (days 14 to 28) (n ¼ 4),
and the interval phase (days 13 to 14) (n ¼ 2) of the menstrual
cycle were available.
A monolayer of cells was prepared from the ThinPrep vial
with the use of the ThinPrep processor 2000. This is an automated system that disperses the cells in the solution, collects
them on the TransCyt filter, and deposits them on a ThinPrep
slide. The slide was then placed in a vial containing 95% alcohol. The slides also underwent a treatment step to remove
any molecular contamination by hemoglobin, which obscures
several features of the cellular spectrum.23 Briefly, slides were
treated with a 30% solution of H2 O2 at room temperature for
3 min, followed by a 70% solution of industrial methylated
spirits (IMS) for 3 min followed by multiple dips into 100%
IMS to remove any remaining cellular debris and H2 O2 . The
slide was then dried in air.

2.2

Raman Spectroscopy

A HORIBA Jobin Yvon XploRA system (Villeneuve d’Asq,
France), which is coupled to an Olympus microscope BX41,
was used for spectral acquisition. As a source, a 532-nm
laser of ∼12-mW power was focused onto the sample using
a 100× objective (MPlanN, Olympus, NA ¼ 0.9) giving a
laser spot of 1 to 2 μm. The resultant Raman signals were
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detected using a spectrograph with a 1200 g∕mm grating
coupled to a charge-coupled device. Raman spectra were
acquired in the fingerprint region, 400 to 1800 cm−1 , with an
integration time of 30 s averaged over two accumulations.
For each slide, spectra from the nucleus or cytoplasm of at
least 30 cells were recorded. The x and y coordinates for each
cell were recorded. A Pap stain was then performed once
a satisfactory number of cells were recorded. This allowed confirmation of the cytological status of the recorded cells using the
previously saved coordinates on the glass slide. Both the glass
coverslip and the Pap stain interfere with Raman measurements,

and so the confirmatory Pap stain could be carried out only
after all Raman measurements were taken.

2.3

Data Analysis

All preprocessing and analyses were carried out using
MATLAB version 7.9 (2009). Preprocessing steps involved
smoothing (Savitzky–Golay k ¼ 5, w ¼ 13), baseline correction
(rubber band), and vector normalization. The contribution from
the glass slide was removed using a nonnegatively constrained
least squares method as described in more detail in Ref. 38.

Fig. 1 Unstained and Pap-stained cervical exfoliated cells. (a) and (b) Superficial cells, (c) and (d) intermediate cells, and (e) and (f) parabasal cells (circled), unstained and stained, respectively. Bar ¼ 20 μm.
Journal of Biomedical Optics
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The data were then subjected to principal component analysis
(PCA), an unsupervised multivariate statistical technique
allowing evaluation of the variability existing in the data sets.39
Moreover, to better appreciate the discrimination achieved by
comparison of the Raman spectra, a factorial discriminant analysis (FDA) has been performed on the scores calculated from the
PCA.39 The optimal number of principal components (PCs) to
generate the PCA–FDA model was found to be 10 PCs. The
output of the analysis can be represented by means of a confusion matrix with all data points attributed to the groups identified
by the operator (superficial, intermediate, parabasal, and HSIL
cells). The statistical relevancy and robustness of the analysis
have been ensured using a 100-fold cross validation, where
two-thirds of the spectra have randomly been selected as the
calibration set, whereas the remaining third is used as the validation set, thus over 100 independent iterations. The overall
classification obtained is represented by the sensitivity and
specificity.

3

(a)

(b)

Results and Discussion

3.1

Raman Spectral Signatures of Superficial,
Intermediate, and Parabasal Cells

The main aim of the study was to define the spectral signatures
of the normal cervical epithelial cell types present on a Pap test
specimen. Figure 1 shows typical superficial, intermediate,
and parabasal cells on a Pap stained ThinPrep slide. When
unstained, superficial and intermediate cell types can be difficult
to differentiate [Figs. 1(a) and 1(c)]. The smallest of the three
cell types is the parabasal cells [Fig. 1(e)]. As the parabasal cells
mature into intermediate and superficial cells, the nucleus
shrinks and the cell enlarges. Thus, the superficial and intermediate cells can be differentiated quite well visually from the
parabasal cells on the basis of the nucleus to cytoplasm ratio.
After Pap staining, superficial cells tend to stain pink due to
their metabolic inactivity [Fig. 1(b)], while the metabolically
active intermediate and parabasal cells are usually stained blue
[Figs. 1(d) and 1(f)].
3.1.1

Raman spectral signatures of superficial,
intermediate, and parabasal cell nuclei

Figure 2(a) shows mean Raman spectra recorded from the nuclei
of cytologically normal cervical exfoliated cells. Cells were confirmed as superficial, intermediate, or parabasal by Pap staining
after Raman spectral recording. Noticeable spectral differences
between the nuclei of superficial, intermediate, and parabasal
cells can be seen at 480, 782, 1339, 1450, and 1670 cm−1 . A
separation of the groups can be seen in the PCA scatter plot
[Fig. 2(b)], with PC1 almost completely separating the superficial cell spectra from the intermediate cell spectra, and PC2
providing reasonable separation of the parabasal cell spectra
from the spectra of the superficial and intermediate cells. Some
degree of overlap between the different groups might be
expected given the progressive maturation of the cells, some
cells may be between parabasal and intermediate stages and
some between the intermediate and superficial stages. The loadings corresponding to PC1 and PC2, shown in Fig. 2(c), confirm
the visual observations, with the majority of the discrimination
coming from the peaks mentioned previously. In the PCA scatter
plot, the spectra of the superficial cells are on the negative side
of PC1 and the spectra of the intermediate cells are on the
Journal of Biomedical Optics

(c)

Fig. 2 (a) Mean Raman spectra of superficial (blue), intermediate
(green), and parabasal (red) cell nuclei. Shading denotes the standard deviation. Spectra have been offset for clarity. (b) PCA scatter
plot and (c) loadings corresponding to the first (red) and second
(green) PCs.

positive side. Thus, the negative features of the PC1 loading elucidate the discriminating Raman features, which can be attributed to the superficial cells, including glycogen and nucleic acid
bands at 480, 1380, and 1490 cm−1 and the positive features can
be attributed to the intermediate cells, including protein bands
at 1450 and 1670 cm−1 .12,13 Despite the Raman spectra being
recorded from the nuclei, glycogen features are stronger in
the superficial cells as would be expected as these cells are
more mature. Signals from glycogen would have been collected
from the cytoplasm overlying the nuclei in the superficial cells.
In addition, the superficial cell nuclei are denser than the intermediate cell nuclei resulting in compacted chromatin, which
produces a stronger Raman signal. The more prominent protein
features in the intermediate cells may be due to a greater degree
of transcription in these cells in comparison to the superficial
cells, as intermediate cells are still metabolically active, in comparison to the mature superficial cells, which are at the end of
their life cycle. The parabasal cell spectra are reasonably well
discriminated from both cell types by PC2. The PC2 loading
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mainly consists of negative features, which can be attributed to
the superficial and intermediate cells, with contributions coming
from peaks at 480 and 1339 cm−1 (glycogen), 722, 782, 1096,
1485, and 1576 cm−1 (nucleic acids), and 1670 cm−1 (proteins).
It would be expected that the parabasal cells would have
stronger nucleic acid features as they are immature, rapidly proliferating cells and this has previously been shown for cervical
tissue ex vivo, where spectral maps were recorded across the
different cell layers.14,15 As spectra were recorded from cell
nuclei, the finding here most likely reflects the large difference
in nuclear size between the parabasal cells and the superficial
and intermediate cells resulting in less compacted chromatin
and weaker Raman signals.

3.1.2

Raman spectral signatures of superficial and
intermediate cell cytoplasm

Figure 3(a) shows Raman spectra recorded from the cytoplasm
of cytologically normal cervical exfoliated cells. Cells were
confirmed as superficial or intermediate by Pap staining after
Raman spectral recording. It was not possible to record spectra
from the cytoplasm of parabasal cells as the nucleus is very large
in these immature cells and there is very little cell cytoplasm.
Very distinct spectral differences between the cytoplasm of
superficial and intermediate cells can be seen at 480, 850,
938, 1082, and 1336 cm−1 . These characteristic glycogen
bands12,13 are more prominent in the spectra from the cytoplasm

(a)

(b)

(c)

Fig. 3 (a) Raman spectra of superficial (blue) and intermediate
(green) cell cytoplasm. (b) PCA scatter plot and (c) loadings corresponding to the first PC.

Journal of Biomedical Optics

Fig. 4 (a) Raman spectra of the cytoplasm of superficial cells from
samples taken at different days of the menstrual cycle, days 5 to
13 (blue), days 13 to 14 (red), and days 14 to 28 (green), (b) PCA
scatter plot, and (c) loadings corresponding to the first PC.
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of superficial cells. A separation of the two groups can be seen
in the PCA scatter plot [Fig. 3(b)], with PC1 almost completely
separating the superficial cell spectra from the intermediate
cell spectra. The loadings corresponding to PC1 are shown in
Fig. 3(c) with negative peaks corresponding to the superficial
cells, including glycogen bands at 480, 850, 938, 1082, and
1336 cm−1 . Positive peaks correspond to the intermediate
cells and are dominated by protein bands at 1450 and
1670 cm−1 . As observed previously with the spectra from the
cell nuclei, glycogen features are stronger in the superficial
cells as would be expected as these cells are more mature
and accumulate more glycogen than the intermediate cells.34
More prominent protein features were again observed in the
spectra from the intermediate cells as these cells are metabolically active compared to the superficial cells.
These findings agree well with previous studies on cervical
tissue ex vivo, where the main spectral difference observed was
increased glycogen features in the superficial cell layer.14,15
Raman spectra from the cytoplasm of the superficial cells
were found to be quite variable, within individual cells and
between samples. To investigate this further, an additional
set of cytologically normal samples was obtained, where the
phase of the menstrual cycle had been confirmed on an endometrial biopsy.
Figure 4(a) shows Raman spectra recorded from the cytoplasm of cytologically normal cervical exfoliated cells from
samples taken on different days of the menstrual cycle. Only
cells that were confirmed as superficial by Pap staining after
Raman spectral recording were used for this analysis.
Raman spectra taken from the cytoplasm of superficial cells
from the secretory phase (days 14 to 28) displayed prominent
glycogen related peaks at 480, 850, 938, 1125, 1339, and
1380 cm−1 ,12,13 compared to the superficial cell spectra from
the proliferative phase (days 5 to 13).
A reasonable separation of the two groups along PC1 can be
seen in the PCA scatter plot [Fig. 4(b)]. The loadings corresponding to PC1 are shown in Fig. 4(c) with positive peaks
corresponding to the superficial cells at days 14 to 28, including
glycogen bands at 480, 850, 938, 1125, 1339, and 1380 cm−1 .
The spectra recorded from the superficial cells at days 13 to 14
can be seen across both sides of PC1.
Similar findings were observed in an infrared spectroscopy
study by Romeo et al.40 where spectral changes in the 1200 to

1000 cm−1 region due to glycogen were reported throughout
the menstrual cycle. However, a recent study from our group
showed some changes in glycogen related peaks in the spectra
from the nuclei of intermediate cells but no significant difference
in glycogen in the spectra from the nuclei of superficial cells
across the menstrual cycle.33 As spectra were recorded from
the cell nuclei in the study by Traynor et al.33 rather than
from the cytoplasm as in this study or from cell pellets as in
the study by Romeo et al.,40 no significant variability due to
glycogen was observed and Raman spectroscopy was shown
to discriminate well between negative cytology samples taken
across different days of the menstrual cycle and HSIL cytology
samples.

3.2

Comparison of the Spectral Signature of HSIL
Cell Nuclei with that of Superficial, Intermediate,
and Parabasal Cell Nuclei

A second aim of the study was to compare the spectral signature
of HSIL cells to each of the normal cervical epithelial cell types,
superficial, intermediate, and parabasal cells. Spectra were not

Fig. 6 Mean Raman spectra of superficial (blue), intermediate
(green), parabasal (red), and HSIL (black) cell nuclei. Shading denotes
the standard deviation. Spectra have been offset for clarity.

Fig. 5 (a) Unstained and (b) pap-stained cervical exfoliated cell confirmed as HSIL (arrow). Bar ¼ 20 μm.
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recorded from the cytoplasm as HSIL cells consist almost
entirely of an enlarged nucleus, with very little cytoplasm
(Fig. 5).
Figure 6 shows mean Raman spectra recorded from the
nuclei of HSIL and normal cervical exfoliated cells. Cells
were confirmed as HSIL, superficial, intermediate, or parabasal
by Pap staining after Raman spectral recording. Spectral
differences between the nuclei of HSIL cells and superficial,
intermediate, and parabasal cells were observed at 480, 850,
938, 1125, 1339, 1450, and 1650 cm−1 .
PCA was performed, where the spectra from HSIL cell nuclei
were compared to the spectra from nuclei of each normal cell
type. Each PCA plot and the corresponding loadings are shown

in Fig. 7. Figure 7(a) shows good discrimination between superficial cells and HSIL cells along PC1. In the PCA scatter plot,
the spectra of the superficial cells are on the negative side of
PC1 and the spectra of the HSIL cells are on the positive side.
Thus, the negative loadings of PC1 elucidate the discriminating
Raman features, which can be attributed to the superficial
cells, including glycogen peaks at 480, 850, 938, 1333, and
1380 cm−1 and nucleic acid peaks at 780, 1490, and 1580 cm−1
[Fig. 7(b)]. Figure 7(c) shows good discrimination between
intermediate cells and HSIL cells along PC1. Again, the negative loadings of PC1 display the Raman features, which can be
attributed to the intermediate cells, including a glycogen-related
peak at 1333 cm−1 and protein peaks at 1450 and 1650 cm−1

(a)

(b)

(c)

(d)

(e)

(f)

Fig. 7 (a) PCA scatter plot of spectra from the nuclei of superficial cells (blue) and HSIL cells (red) and
(b) loadings corresponding to the first PC. (c) PCA scatter plot of spectra from the nuclei of intermediate
cells (blue) and HSIL cells (red) and (d) loadings corresponding to the first PC. (e) PCA scatter plot of
spectra from the nuclei of parabasal cells (blue) and HSIL cells (red) and (f) loadings corresponding to
the second PC.

Journal of Biomedical Optics

105008-7

Downloaded From: https://www.spiedigitallibrary.org/journals/Journal-of-Biomedical-Optics on 20 Sep 2019
Terms of Use: https://www.spiedigitallibrary.org/terms-of-use

October 2017

•

Vol. 22(10)

Kearney et al.: Raman spectral signatures of cervical exfoliated cells from liquid-based. . .
Table 1 Sensitivity and specificity for PCA–FDA classification of negative cytology versus HSIL cytology using spectra from superficial,
intermediate, parabasal cells, or all cell types combined.

Sensitivity (%)

Specificity (%)

Superficial cells (negative)
versus HSIL

99

100

Intermediate cells (negative)
versus HSIL

96

99

Parabasal cells (negative)
versus HSIL

89

90

Combined negative cells
versus HSIL

92

97

[Fig. 7(d)]. Significant overlap was observed in the PCA scatter
plot of the spectra from the nuclei of the parabasal cells and the
HSIL cells [Fig. 7(e)]. This might be expected given their morphological and potential biochemical similarity as HSIL cells
arise from the basal/parabasal layer of cervical tissue. Some
discrimination was observed, however, along PC2. The positive
loadings of PC2 can be attributed to the HSIL cells with peaks at
1080, 1450, and 1650 cm−1 [Fig. 7(f)].
To further quantify the ability of Raman spectroscopy to
discriminate between negative and HSIL cytology, PCA–
FDA was performed using spectra from superficial, intermediate, parabasal cells, or from all cell types combined (Table 1).
Table 1 shows very good classification of both superficial and
intermediate cells and HSIL cells (sensitivity of 99% and 96%
and specificity of 100% and 99%, respectively). Classification
of parabasal and HSIL cells is more challenging because of their
morphological and biochemical similarity as noted earlier, but
despite this, good sensitivity and specificity were achieved (sensitivity of 89% and specificity of 90%). Interestingly, when all
negative cytology cell types were combined (superficial, intermediate, and parabasal cells), good classification of negative
cytology and HSIL cytology could be achieved (sensitivity of
92% and specificity of 97%).
In previous studies on cervical exfoliated cells, similar
features of glycogen (482, 852, 937, 1339, and 1380 cm−1 )
and nucleic acids (786, 1485, and 1580 cm−1 ) were reported to
be more prominent in superficial and intermediate cells confirmed as cytology negative compared to HSIL cells.22,23 The
more prominent protein features observed in the HSIL cells
compared to the normal parabasal cells in this study may be
reflective of a transforming HPV infection controlling the
cellular machinery in the HSIL cells.

4

in the intermediate cells as these cells are still metabolically
active in comparison to the mature superficial cells.
Intermediate and superficial cells could be discriminated from
parabasal cells on the basis of more prominent glycogen, nucleic
acid, and protein features, most likely because of the larger
nucleus to cytoplasm ratio of parabasal cells resulting in weaker
Raman signals. Raman spectra from the cytoplasm of superficial
cells showed very prominent glycogen peaks, which varied
depending on where in the cytoplasm the spectra were recorded
but also between samples. This variability between samples was
shown to be due to different levels of glycogen in different
phases of the menstrual cycle. In the comparisons to the
HSIL cells, only Raman spectra from the nuclei of superficial,
intermediate, and parabasal cells were used because of the
variability observed in the spectra from the cytoplasm and
also because the HSIL cells were composed of a large nucleus
with very little cytoplasm. Glycogen (482, 852, 937, 1339, and
1380 cm−1 ) and nucleic acid (786, 1485, and 1580 cm−1 )
features were observed to be more prominent in superficial
and intermediate cells compared to HSIL cells. Interestingly,
more prominent protein features were observed in the HSIL
cells compared to the parabasal cells potentially as a result of
a transforming HPV infection. Sensitivity of >96% and specificity of >99% were achieved for classification of superficial
and intermediate cells from HSIL cells and sensitivity of
89% and specificity of 90% were achieved for classification of
parabasal cells and HSIL cells despite the morphological and
biochemical similarity. Good classification was also achieved
when all negative cytology cell types (superficial, intermediate,
and parabasal cells) were combined (sensitivity of 92% and
specificity of 97%).
Good quality Raman signals with minimal variability could
be recorded from the nucleus of the normal and abnormal cells.
Raman spectra recorded from the cytoplasm showed a lot more
variability due to glycogen accumulations in the superficial cells
and this was also found to vary depending on the phase of the
menstrual cycle.
Intermediate and superficial cells are the most common cell
types present on a liquid-based cytology Pap test specimen.
Although it can be difficult to distinguish the two cell types morphologically on the unstained slide, they can be discriminated
using Raman spectroscopy based on their biochemical signatures. In addition, both cell types can be discriminated from
HSIL cells again based on their biochemical signatures.
Parabasal cells are less commonly seen on most Pap test specimens and although they have a similar morphology to HSIL
cells, they can be discriminated from HSIL cells based on
their biochemical signature. This study has shown the potential
of biochemical fingerprinting using Raman spectroscopy for
cervical cancer screening using standard liquid-based cytology
preparation methods.

Conclusion

In this study, specific Raman spectral signatures were shown for
each of the three most common cell types seen in ThinPrep
liquid-based cytology samples, superficial, intermediate, and
parabasal cells. Moreover, using PCA, it was shown that the
spectra of each of these cell types could be differentiated
from one another. An increase in glycogen (480, 850, 938,
1082, and 1336 cm−1 ) was observed as cells matured from
parabasal to intermediate to superficial cells. Intermediate cell
spectra exhibited stronger protein related peaks (1450 and
1670 cm−1 ) suggesting a greater degree of protein production
Journal of Biomedical Optics
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